Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell CarcinomaJ. Clin. Oncol 2021 Feb 02;[EPub Ahead of Print], DF McDermott, JL Lee, GA Bjarnason, JMG Larkin, RA Gafanov, MD Kochenderfer, NV Jensen, F Donskov, J Malik, A Poprach, SS Tykodi, T Alonso-Gordoa, DC Cho, PF Geertsen, MA Climent Duran, C DiSimone, RK Silverman, RF Perini, C Schloss, MB Atkins
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.